SCHEMBL23832547

SCHEMBL23832547

O=C1CCCC(=O)N1n1c(=O)[nH]c2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.48
▸ MAPT P10636 2/20 0.48
▸ DAO P14920 1/20 0.47
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.42
▸ HPGD P15428 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ OPRM1 P35372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30225525 0.78 LMNA (0.41) LMNAMAPTDAOMEN1KMT2A
SCHEMBL2718551 0.75 LMNA (0.51) LMNAMAPTDAOMEN1KMT2A
SCHEMBL5204992 0.70 DAO (0.47) LMNAMAPTDAOMEN1KMT2A
SCHEMBL23832563 0.69 ALDH1A1 (0.41) LMNAMEN1KMT2ACYP1A2ALDH1A1
SCHEMBL3702314 0.69 DAO (0.59) LMNAMAPTDAOMEN1KMT2A
Hydrochloric Acid SCHEMBL30509213 0.68 ALDH1A1 (0.41) LMNAMEN1KMT2ACYP1A2ALDH1A1
SCHEMBL5657114 0.67 OPRM1 (0.45) DAOHPGDCHRM2CHRM4CHRM1
SCHEMBL7220315 0.67 DAO (0.44) LMNAMAPTDAOMEN1KMT2A
SCHEMBL30368512 0.67 TSHR (0.46) LMNAHPGDALDH1A1TSHRMAPK1
SCHEMBL29991182 0.66 DAO (0.61) LMNAMAPTDAOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119013277-A TYK2 degrading agent and application thereof 凯麦拉医疗公司 2024-11-22 — — CN disclosed
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
EP-4121043-A1 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-01-25 — — EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
WO-2021188948-A1 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-09-23 — — WO disclosed
Send feedback